Year-end Sale % OFF 
Abstract
The misuse of anabolic androgenic steroids (AAS) and other performance enhancing (ergogenic) drugs remains largely unrecognized by many health professionals. The real extent of the problem is unknown, probably as a result of a combination of various methodological difficulties. Examples include poor definition of cases, obstacle in recruiting large enough samples for longitudinal follow-up, ethical issues as AAS are obtained from the black market and the covert nature of the problem itself. Our review attempts to alert psychiatrists and mental health professionals to the risks associated with these compounds. We cover the pharmacology, epidemiology, the use and misuse and relevant complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Psychiatry in Clinical Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
